Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer

Clinical trial NCT07229339 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07229339
Sponsor: Jonsson Comprehensive Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Non-Squamous Non-Small Cell Carcinoma

Start date: 2027-06-01
Primary completion: 2029-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.